Elekta has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its adaptive Elekta Evo linear accelerator, Elekta Evo CT-Linac.
Also CE-marked in Europe, Elekta Evo is designed with Iris AI-enhanced image reconstruction to improve image-guided radiation therapy (IGRT) treatments. Using Iris high-definition conebeam CT, the system reduces scatter and enhances image reconstruction, according to the firm.
![A 53-year-old patient (patient number four) with a recurrent pituitary adenoma with extension of a cystic component of disease to the medial temporal lobe apparent on MRI (contoured in blue), and extension of disease to the left sphenoid bone and orbital apex apparent on [68Ga]Ga-DOTA-TATE (contoured in yellow).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/pituitary-tumor.QGsEnyB4bU.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
